Moore Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Moore Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell
2019 Q3	$632K	Buy
2019 Q2	$617K	Hold
2019 Q1	$464K	Hold
2018 Q4	$420K	Hold
2018 Q3	$627K	Buy
2014 Q1	–	Sell
2013 Q4	$506K	Buy
2013 Q3	$252K	Buy